Department of Anesthesiology and Perioperative Medicine, Division of Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.
HEModynamic and AIRway Management (HEMAIR) Study Group, Mayo Clinic, Rochester, MN, USA.
J Intensive Care Med. 2023 Dec;38(12):1108-1120. doi: 10.1177/08850666231183401. Epub 2023 Jun 15.
Cardiovascular instability occurring during endotracheal intubation (ETI) in the critically ill is a commonly recognized phenomenon. However, this complication has not been evaluated in terms of the physiological cause (ie, decreased preload, contractility, or afterload) leading to the instability. Thus, the aim of the current investigation was to describe the hemodynamics occurring during ETI with noninvasive physiologic monitoring and to collect preliminary data on the hemodynamic effects of induction agents and positive pressure ventilation. A multicenter prospective study enrolling adult (≥18 years) critically ill patients undergoing ETI with noninvasive cardiac output monitoring in a medical/surgical intensive care unit from June 2018 to May 2019 was conducted. This study used the Cheetah Medical noninvasive cardiac output monitor to collect hemodynamic data during the peri-intubation period. Additional data collected included baseline characteristics such as illness severity, peri-intubation pharmacologic administration, and mechanical ventilation settings. From the original 27 patients, only 19 (70%) patients had complete data and were included in the final analysis. Propofol was the most common sedative 8 (42%) followed by ketamine 6 (32%) and etomidate 5 (26%). Patients given propofol demonstrated a decrease in total peripheral resistance index (delta change [dynes × s/cm/m]: -2.7 ± 778.2) but stabilization in cardiac index (delta change (L/min/m]: 0.1 ± 1.5) while etomidate and ketamine demonstrated increases in total peripheral resistance index (etomidate delta change [dynes × s/cm/m]: 302.1 ± 414.3; ketamine delta change [dynes × s/cm/m]: 278.7 ± 418.9) but only etomidate resulted in a decrease in cardiac index (delta change [L/min/m]: -0.3 ± 0.5). Positive pressure ventilation resulted in minimal changes to hemodynamics during ETI. The current study demonstrates that although propofol administration leads to a decrease in total peripheral resistance index, cardiac index is maintained while etomidate leads to a decrease in cardiac index with both etomidate and ketamine increasing total peripheral resistance index. These hemodynamic profiles are minimally affected by positive pressure ventilation. ClinicalTrials.gov ID, NCT03525743.
在危重病患者中,气管插管(ETI)期间发生心血管不稳定是一种常见现象。然而,尚未根据导致不稳定的生理原因(即前负荷降低、收缩性降低或后负荷降低)来评估这种并发症。因此,目前的研究旨在描述使用非侵入性生理监测在 ETI 期间发生的血液动力学,并收集诱导剂和正压通气对血液动力学影响的初步数据。
一项多中心前瞻性研究于 2018 年 6 月至 2019 年 5 月在医疗/外科重症监护病房对接受非侵入性心输出量监测的成年(≥18 岁)危重病患者进行了 ETI。该研究使用 Cheetah Medical 非侵入性心输出量监测仪在围插管期间收集血液动力学数据。收集的其他数据包括疾病严重程度、围插管期药物管理和机械通气设置等基线特征。
在最初的 27 名患者中,只有 19 名(70%)患者有完整的数据并纳入最终分析。最常用的镇静剂是丙泊酚 8 例(42%),其次是氯胺酮 6 例(32%)和依托咪酯 5 例(26%)。给予丙泊酚的患者外周血管阻力指数降低(变化量 [dynes×s/cm/m]:-2.7±778.2),但心指数稳定(变化量 [L/min/m]:0.1±1.5),而依托咪酯和氯胺酮的外周血管阻力指数增加(依托咪酯变化量 [dynes×s/cm/m]:302.1±414.3;氯胺酮变化量 [dynes×s/cm/m]:278.7±418.9),但只有依托咪酯导致心指数降低(变化量 [L/min/m]:-0.3±0.5)。正压通气在 ETI 期间对血液动力学几乎没有影响。
目前的研究表明,尽管丙泊酚的使用会导致外周血管阻力指数降低,但心指数维持不变,而依托咪酯则导致心指数降低,同时依托咪酯和氯胺酮都会增加外周血管阻力指数。这些血液动力学特征受正压通气的影响很小。
临床试验.gov 标识符,NCT03525743。